PBPK.org - MEGen section added to forum

Search News

Login

Syndicate

ATOM 0.3

OPML

Latest PBPK papers

Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling: Two Cytochrome P450 3A4 Substrates Coadministered with Ketoconazole or Verapamil.
A physiologically based pharmacokinetic (PBPK) model for predicting the efficacy of drug overdose treatment with liposomes in man.
Generic parameterization for a pharmacokinetic model to predict Cd concentrations in several tissues of different fish species.
Physiologically Based Pharmacokinetic Modeling of Deltamethrin: Development of a Rat and Human Diffusion-limited Model.
Physiologically based modeling of p-tert-octylphenol kinetics following intravenous, oral or subcutaneous exposure in male and female Sprague-Dawley rats.
Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity.
Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.
Design and Application of Microfluidic Systems for In vitro Pharmacokinetic Evaluation of Drug Candidates.

MEGen section added to forum

PDF

Print

E-mail

Written by Martin Spendiff
Wednesday, 08 August 2007
An area dedicated to the discussion of HSL's recently-released PBPK model generator, MEGen, has been added to the forum section. Since MEGen is pre-alpha open-source software, intended to be a freely-available community resource. The primary purpose of the forum is for users and developers to submit code, discuss bugs, highlight issues and supply feature requests. WARNING: MEGen is optimised for firefox, so use that if you can. Failing that, please upgrade your copy of Internet Explorer to IE7.
Last Updated ( Friday, 09 May 2008 )

< Prev		Next >

: Sitemap : © Martin Spendiff 2008